Axsome Therapeutics AXSM Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's total assets?
- Axsome Therapeutics (AXSM) reported total assets of $713.61M in Q1 2026.
- How has Axsome Therapeutics's total assets changed year-over-year?
- Axsome Therapeutics's total assets increased by 19.6% year-over-year, from $596.67M to $713.61M.
- What is the long-term trend for Axsome Therapeutics's total assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's total assets has grown at a 30.0% compound annual growth rate (CAGR), from $186.13M to $689.81M.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- An increase typically indicates asset growth through investment or acquisition, while a decrease may signal asset liquidation or impairment.
- How does total assets compare across companies?
- Varies significantly by company size and stage of clinical development.